Local VCs more worried about FDA moves than healthcare reform

May 3, 2010 by MassDevice staff

A small survey of the New England Venture Network by MassDevice.com shows real concern among local investors over moves made by the Food & Drug Administration.

VC logo

Concerns in the investment community over changes in the 510(k) clearance process and other uncertainty over new regulation at the Food & Drug Administration outweigh worries about the healthcare reform act, according to a MassDevice survey of local med-tech investors.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.